| Robin Farley, PT | |
|
243 North Road, Poughkeepsie, NY 12601-1172 | |
| (845) 485-5087 | |
| (845) 485-4904 |
| Full Name | Robin Farley |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 243 North Road, Poughkeepsie, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720206733 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 022187 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Robin Farley, PT 16 Flanders Road, Wappingers Falls, NY 12590-1623 Ph: (845) 431-8202 | Robin Farley, PT 243 North Road, Poughkeepsie, NY 12601-1172 Ph: (845) 485-5087 |
News Archive
To help patients with muscle disorders, scientists at The University of Texas Health Science Center at Houston (UTHealth) have engineered a new stem cell line to study the conversion of stem cells into muscle. Findings appeared in Cell Reports.
A protein previously thought not to exist in adult human lungs not only is present in normal and cancerous lung tissue, scientists have found, but it also has a major role in the development of a lethal complication of some lung cancers.
University of Alberta researcher Flora Wang found that a diet with enriched levels of trans vaccenic acid (VA) - a natural animal fat found in dairy and beef products - can reduce risk factors associated with heart disease, diabetes and obesity
Specific combinations of gut bacteria produce substances that affect myelin content and cause social avoidance behaviors in mice, according to a study conducted at the Icahn School of Medicine at Mount Sinai and published today in the medical journal eLife. This research suggests that targeting intestinal bacteria, or their metabolites, could be one way to treat debilitating psychiatric disorders and demyelinating diseases, like multiple sclerosis.
QLT Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for QLT091001, its oral synthetic retinoid, for the treatment of Leber Congenital Amaurosis (LCA). LCA is an inherited progressive retinal degenerative disease that leads to retinal dysfunction and visual impairment beginning at birth. QLT091001 is an orally administered synthetic retinoid replacement for 11-cis-retinal, which is a key biochemical component of the visual retinoid cycle.
› Verified 3 days ago
Dr. Mark Joao, DPT, CSCS Physical Therapist Medicare: Medicare Enrolled Practice Location: 301 Manchester Rd Ste 101, Poughkeepsie, NY 12603 Phone: 845-454-4137 | |
Kevin Paul Marquis, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2 Austin Ct, Poughkeepsie, NY 12603 Phone: 845-471-3017 Fax: 845-471-3073 | |
Heather Ann Vicari, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4 Hawthorne Ln, Poughkeepsie, NY 12603 Phone: 845-463-5661 | |
Mrs. Shiela Rubia Jabujab, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 100 Franklin St, Poughkeepsie, NY 12601 Phone: 845-454-4100 Fax: 845-454-4175 | |
Michele Ann Hyland, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 301 Manchester Rd Ste 101, Poughkeepsie, NY 12603 Phone: 845-545-4137 | |
Miss Margrit T Bunk, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 241 North Road, St Fancis Hospital, Poughkeepsie, NY 12601 Phone: 845-431-8202 | |
Miss Jamie Lee Mills, MSPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 241 North Road, Poughkeepsie, NY 12601 Phone: 845-431-8803 |